OS-2966

• Target:

  Integrin

• Related Pathways:

  Cytoskeletal Signaling

• Purity:

  0.9935

• Bioactivity:

  OS-2966 is a humanised de-immunised monoclonal antibody that targets and inhibits the adhesion receptor subunit Integrin b1/ITGB1/CD29, and can be used for the treatment of malignant gliomas, glioblastomas, and astrocytomas.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C